Introduction: cardiovascular safety and triptans in the acute treatment of migraine

Headache. 2004 May:44 Suppl 1:S1-4. doi: 10.1111/j.1526-4610.2004.04102.x.

Author

David W Dodick¹

Affiliation

¹ Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA.

PMID: 15149487
DOI: 10.1111/j.1526-4610.2004.04102.x

No abstract available

MeSH terms

Acute Disease
Coronary Disease / chemically induced
Evidence-Based Medicine
Humans
Migraine Disorders / drug therapy*
Myocardial Ischemia / chemically induced
Risk Factors
Serotonin Receptor Agonists / adverse effects
Serotonin Receptor Agonists / therapeutic use*
Vasoconstrictor Agents / adverse effects
Vasoconstrictor Agents / therapeutic use

Substances

Serotonin Receptor Agonists
Vasoconstrictor Agents